Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.87 USD | -2.65% | -7.27% | -25.13% |
Apr. 08 | North American Morning Briefing : Inflation Data, -2- | DJ |
Apr. 05 | Oppenheimer Upgrades AngioDynamics to Outperform From Perform, $12 Price Target | MT |
Financials (USD)
Sales 2024 * | 287M | Sales 2025 * | 287M | Capitalization | 235M |
---|---|---|---|---|---|
Net income 2024 * | -194M | Net income 2025 * | -43M | EV / Sales 2024 * | 0.82 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.82 x |
P/E ratio 2024 * |
-1.27
x | P/E ratio 2025 * |
-6.6
x | Employees | 815 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.13% |
Latest transcript on AngioDynamics, Inc.
1 day | -2.65% | ||
1 week | -7.27% | ||
1 month | +9.51% | ||
3 months | -2.17% | ||
6 months | -11.33% | ||
Current year | -25.13% |
Managers | Title | Age | Since |
---|---|---|---|
James Clemmer
CEO | Chief Executive Officer | 60 | 16-03-31 |
Director of Finance/CFO | 49 | 08-05-31 | |
Juan Serna
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jan Reed
BRD | Director/Board Member | 64 | 16-11-08 |
Howard Donnelly
CHM | Chairman | 63 | 04-02-29 |
Wesley Johnson
BRD | Director/Board Member | 65 | 07-01-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 27 M€ | -4.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 5.87 | -2.65% | 586,457 |
24-04-23 | 6.03 | -3.67% | 379,009 |
24-04-22 | 6.26 | 0.00% | 336,227 |
24-04-19 | 6.26 | +2.29% | 479,291 |
24-04-18 | 6.12 | -3.32% | 806,891 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.13% | 235M | |
-2.89% | 185B | |
-2.43% | 107B | |
-4.10% | 67.55B | |
+11.10% | 54.6B | |
+15.86% | 47.42B | |
+3.86% | 42.24B | |
+9.55% | 28.24B | |
+1.85% | 26.42B | |
+12.40% | 25.66B |
- Stock Market
- Equities
- ANGO Stock